Matches in Wikidata for { <http://www.wikidata.org/entity/Q81821348> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q81821348 description "artículu científicu espublizáu en setiembre de 2005" @default.
- Q81821348 description "im September 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81821348 description "scientific article published on 01 September 2005" @default.
- Q81821348 description "wetenschappelijk artikel" @default.
- Q81821348 description "наукова стаття, опублікована у вересні 2005" @default.
- Q81821348 name "Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling" @default.
- Q81821348 name "Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling" @default.
- Q81821348 type Item @default.
- Q81821348 label "Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling" @default.
- Q81821348 label "Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling" @default.
- Q81821348 prefLabel "Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling" @default.
- Q81821348 prefLabel "Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling" @default.
- Q81821348 P1433 Q81821348-9155DC81-F6FB-4730-BC99-24D02ED60EF3 @default.
- Q81821348 P1476 Q81821348-B21EDE6D-5041-41EE-ADCD-1B44A8DC3BF4 @default.
- Q81821348 P2093 Q81821348-22D0EC8A-3CA3-402A-9C90-0B856E953BFC @default.
- Q81821348 P2093 Q81821348-63EE1EFC-8E51-4BEE-B110-8A76B383FBFB @default.
- Q81821348 P2093 Q81821348-7E62673A-E72F-4361-9EFE-6CCD9E1F244A @default.
- Q81821348 P2093 Q81821348-8E8A88D8-C6C0-48A6-87E8-8D8EC168F9A0 @default.
- Q81821348 P2093 Q81821348-E06AA808-5101-4890-85FE-560498836709 @default.
- Q81821348 P304 Q81821348-1F82F6F4-5E85-436F-9FA4-212AFCF0029D @default.
- Q81821348 P31 Q81821348-2F02DC6B-1EC3-44F8-94DB-6C387F73C3BA @default.
- Q81821348 P356 Q81821348-E2AF3292-CC81-4957-A090-F8173ED0CC30 @default.
- Q81821348 P433 Q81821348-7D3C312C-B4D1-46EA-8DFA-6DD254584686 @default.
- Q81821348 P478 Q81821348-D64BFCE4-1826-40FF-9546-C56D5CEBE0E2 @default.
- Q81821348 P50 Q81821348-87EDC55F-B1DA-4D75-94EC-07419C3BEE56 @default.
- Q81821348 P577 Q81821348-C2E0AA0F-BFAF-49DE-880E-9FD9686B4412 @default.
- Q81821348 P698 Q81821348-64CF6613-6752-4D75-A3E4-51012265B1CD @default.
- Q81821348 P356 PBC.20418 @default.
- Q81821348 P698 15940724 @default.
- Q81821348 P1433 Q15754342 @default.
- Q81821348 P1476 "Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling" @default.
- Q81821348 P2093 "Albert N Békássy" @default.
- Q81821348 P2093 "Anna Locasciulli" @default.
- Q81821348 P2093 "Gerard Socié" @default.
- Q81821348 P2093 "Judith C W Marsh" @default.
- Q81821348 P2093 "Monika Fuehrer" @default.
- Q81821348 P304 "359-60; author reply 361-2" @default.
- Q81821348 P31 Q13442814 @default.
- Q81821348 P356 "10.1002/PBC.20418" @default.
- Q81821348 P433 "3" @default.
- Q81821348 P478 "45" @default.
- Q81821348 P50 Q67905482 @default.
- Q81821348 P577 "2005-09-01T00:00:00Z" @default.
- Q81821348 P698 "15940724" @default.